Literature DB >> 29885993

Activated human Foxp3+ regulatory T cells produce membrane-bound TNF.

Alexander Nelson1, Christina Cunha2, Michael I Nishimura3, Makio Iwashima4.   

Abstract

TNF is a multifunctional cytokine that is critical to host defense against pathogens but can also drive the pathophysiology of inflammatory diseases. Inhibition of TNF occasionally causes exacerbation of some autoimmune diseases, suggesting a role for TNF in the regulation of immune homeostasis. Here, we demonstrate that human peripheral blood CD4+CD25+Foxp3+ regulatory T cells (Tregs) express membrane-bound TNF, a potent activator of the type 2 TNF receptor. While the type 1 TNF receptor can cause cell death and is expressed ubiquitously, the type 2 receptor promotes cell growth and its expression is limited mainly to immune and endothelial cells. When autocrine TNF is blocked in an in vitro culture without IL-2, activated Tregs stop proliferating. These data indicate a novel role for TNF as a Treg-derived autocrine growth factor.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Foxp3; IL-2; TNF; Treg

Mesh:

Substances:

Year:  2018        PMID: 29885993      PMCID: PMC6281785          DOI: 10.1016/j.cyto.2018.05.036

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  38 in total

Review 1.  Regulation of tumour necrosis factor signalling: live or let die.

Authors:  Dirk Brenner; Heiko Blaser; Tak W Mak
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

2.  TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

Authors:  J Liu; M W Marino; G Wong; D Grail; A Dunn; J Bettadapura; A J Slavin; L Old; C C Bernard
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

Review 3.  Novel lymphocyte-specific CC chemokines and their receptors.

Authors:  O Yoshie; T Imai; H Nomiyama
Journal:  J Leukoc Biol       Date:  1997-11       Impact factor: 4.962

4.  TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment.

Authors:  Antonio Pierini; William Strober; Caitlin Moffett; Jeanette Baker; Hidekazu Nishikii; Maite Alvarez; Yuqiong Pan; Dominik Schneidawind; Everett Meyer; Robert S Negrin
Journal:  Blood       Date:  2016-06-30       Impact factor: 22.113

5.  Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

Authors:  M J Elliott; R N Maini; M Feldmann; J R Kalden; C Antoni; J S Smolen; B Leeb; F C Breedveld; J D Macfarlane; H Bijl
Journal:  Lancet       Date:  1994-10-22       Impact factor: 79.321

6.  Transmembrane TNF-TNFR2 Impairs Th17 Differentiation by Promoting Il2 Expression.

Authors:  Patrick G Miller; Michael B Bonn; Susan C McKarns
Journal:  J Immunol       Date:  2015-08-12       Impact factor: 5.422

Review 7.  TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer.

Authors:  Henning Walczak
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

8.  TNF Receptor 2 and Disease: Autoimmunity and Regenerative Medicine.

Authors:  Denise L Faustman; Miriam Davis
Journal:  Front Immunol       Date:  2013-12-23       Impact factor: 7.561

9.  Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritis.

Authors:  Dao Xuan Nguyen; Michael R Ehrenstein
Journal:  J Exp Med       Date:  2016-06-06       Impact factor: 14.307

Review 10.  TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease.

Authors:  Melissa K McCoy; Malú G Tansey
Journal:  J Neuroinflammation       Date:  2008-10-17       Impact factor: 8.322

View more
  1 in total

Review 1.  Re-Examining the Role of TNF in MS Pathogenesis and Therapy.

Authors:  Diego Fresegna; Silvia Bullitta; Alessandra Musella; Francesca Romana Rizzo; Francesca De Vito; Livia Guadalupi; Silvia Caioli; Sara Balletta; Krizia Sanna; Ettore Dolcetti; Valentina Vanni; Antonio Bruno; Fabio Buttari; Mario Stampanoni Bassi; Georgia Mandolesi; Diego Centonze; Antonietta Gentile
Journal:  Cells       Date:  2020-10-14       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.